Urmantsev Marat Fayazovich*, Pavlov, Bakeev and Akinyemi

Department of Oncology, Bashkir State Medical University, Russia

*Corresponding Author: Urmantsev Marat Fayazovich, Department of Oncology, Bashkir State Medical University, Russia.

Received: July 11, 2024; Published: July 24, 2024

Abstract

Maintaining: Bladder cancer is a serious problem of modern oncourology due to the annual increase in the number of diagnosed malignant neoplasms of the urinary system. High-risk muscle-invasive and non-muscle-invasive forms are subject to surgical treatment, with open radical cystectomy (ORC) serving as the" gold " standard. Laparoscopic (LRC) and robot-assisted radical cystectomy (RARC) are serious competitors to this method. To date, the robotic method of removing the bladder is the least studied, despite the fact that it seems to be the most technologically advanced and modern.

Objective: to analyze our own results of using robot-assisted interventions in high-risk muscle-invasive and non-muscle-invasive bladder cancer, as well as to study the literature on the use of robot-assisted radical cystectomy in the treatment of malignant neoplasms of the bladder.

Materials and methods: A prospective study was conducted on the basis of the clinic of the BSMU of the Ministry of Health of the Russian Federation with the participation of 70 patients who were diagnosed with bladder cancer (TT1-TT4). The subjects underwent robot-assisted radical cystectomy with various variants of urine derivation.

Results: At the end of the study, the outcomes after RARC were analyzed and evaluated. The primary endpoints were 30-and 90-day complications according to the Clavien-Dindo system. According to secondary indicators, RARC showed a low duration of surgery, intraoperative blood loss.

Conclusion: Robot-assisted radical cystectomy is a serious competitor to open and laparoscopic interventions in terms of early and long-term perioperative parameters. This technique has shown its profitability in the treatment of bladder cancer, demonstrating a sufficient level of effectiveness and safety.

Keywords: Muscle-Invasive Bladder Cancer; High-Risk Non-Muscle-Invasive Bladder Cancer; Robot-Assisted Radical Cystectomy; Open Radical Cystectomy; Laparoscopic Radical Cystectomy

References

1. World Health Organization. International Agency for Research on Cancer. The Global Cancer Observatory. (December, 2020). Bladder Source: Globocan (2020).
2. Shabsigh A., et al. “Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology”. European Urology1 (2009): 164-174.
3. Lowrance WT., et al. “Contemporary open radical cystectomy: analysis of perioperative outcomes”. Journal of Urology 179 (2008): 1313–1318.
4. Ukimura O., et al. “Laparoscopic radical cystectomy and urinary diversion”. Current Urology Report 6 (2005): 118-121.
5. Bochner BH., et al. “Memorial Sloan Kettering Cancer Center Bladder Cancer Surgical Trials Group. A randomized trial of robot-assisted laparoscopic radical cystectomy”. The New England Journal of Medicine 4 (2014): 389-390.
6. Khan MS., et al. “A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)”. European Urology4 (2016): 613-621.
7. Novara G., et al. “Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy”. European Urology3 (2015): 376-401.
8. Guliev BG., et al. “Robot-Assisted and Open Radical Cystectomy: Comparative Analysis of Results”. Urology Herald.1 (2020): 59-68.
9. Challacombe BJ., et al. “The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications”. European Urology 60 (2011): 767-775.
10. Gill I and Cacciamani G. “The changing face of urologic oncologic surgery from 2000-2018 (63141 patients) - impact of robotics”. European Urology 199 (2019): e656-657.
11. Mistretta FA., et al. “Minimally invasive versus open radical cystectomy: long term oncologic outcomes compared”. Translational Andrology and Urology 3 (2020): 1006-1008.
12. Feng D., et al. “Comparative effectiveness of open, laparoscopic and robot-assisted radical cystectomy for bladder cancer: a systematic review and network meta-analysis”. Minerva Urology and Nephrology3 (2020): 251-264.
13. Fonseka T., et al. “Comparing robotic, laparoscopic and open cystectomy: a systematic review and meta-analysis”. Archivio Italiano di Urologia e Andrologia 1 (2015): 41-48.
14. Khan MS., et al. “Long-term Oncological Outcomes from an Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)”. European Urology1 (2020): 110-118.
15. Kim TH., et al. “Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches”. Journal of Endourology7 (2016): 783-791.

Citation

Citation: Urmantsev Marat Fayazovich., et al. “Progress of Robot-Assisted Cystectomy in the Treatment of Muscle-Invasive Bladder Cancer".Acta Scientific Gastrointestinal Disorders 7.8 (2024): 35-38.

Copyright

Copyright: © 2024 Urmantsev Marat Fayazovich., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.